Medically reviewed by Dr Sin Yong · Last reviewed · 3 min read
Published 13 October 2026 · Reviewed by Dr Sin Yong
Xanthelasma (xanthelasma palpebrarum) is a soft, flat, yellowish plaque on the eyelid, made of lipid-laden foam cells in the superficial dermis, most often near the inner corner of the upper lid. It is benign, but about half of patients have abnormal blood lipids, so a fasting lipid panel is standard advice before removal is planned. Established plaques do not clear with creams or time; removal is by ablative laser, excision or chemical agents, and recurrence after any method is documented.
Key facts
ICD-10
H02.6
What's in it
Foam cells: macrophages loaded with lipid, in the superficial dermis; the most common cutaneous xanthoma
The lipid link
About half of patients have dyslipidaemia; a fasting lipid panel is standard advice
Removal
Ablative laser (CO₂ or erbium), surgical excision or chemical agents, matched to size and depth; recurrence is documented after every method
Illustrative image, not a patient.
Where xanthelasma matters on this site
Xanthelasma sits at the junction of the eyelid pages and the skin-growth pages, and it is the one lesion on either that also raises a blood test.
The plaque on the lid is a sign before it is a cosmetic problem, so the blood test comes before the laser.— Dr Sin Yong
Conditions we assess: the hub for skin growths, where xanthelasma is listed with the other eyelid and bump conditions.
Dr Sin Yong's order is the same on every one of these pages: lipid panel first, removal planning second.
Not to be confused with
Three small eyelid lesions are made of three different things, and the dermatoscope mostly confirms what colour and texture already suggest.
Syringoma: firm, skin-coloured to faintly yellow, flat-topped bumps in symmetrical clusters on the lower lids. Under the dermatoscope there is no yellow plaque, only a faint pinkish-brown surface with nothing to express.
Milia: a hard, pearl-white dome, usually single or scattered. The dermatoscope shows a bright white round structure under smooth skin.
Sebaceous hyperplasia: a yellowish dome with a central dell, on the forehead and cheeks rather than the lid. Dermoscopy shows yellow-white lobules with vessels that run around the edge and do not cross the centre.
Xanthelasma itself: soft, flat, uniformly yellow and sharply bordered, near the inner corner of the upper lid, often on both sides. Dermoscopy shows a homogeneous yellow area without a pearl, lobules or a vessel pattern.
A plaque that is firm, growing quickly or ulcerated is not treated as xanthelasma without examination, because the lid is also where basal cell carcinoma appears.
The site is the first clue: a yellow lesion at the inner upper lid is xanthelasma until proven otherwise; the same colour on the cheek is usually a gland.
What decides whether xanthelasma matters for you
A plaque is benign, so what decides the plan is the lipid picture, the plaque itself and the eyelid it sits on.
The fasting lipid panel: about half of patients have abnormal lipids. An abnormal result is managed by your physician alongside, because recurrence is more likely where lipids stay untreated.
Size and depth: a thin superficial plaque and a thick, deep one are removed differently; ablative laser, excision and chemical agents each have their place.
Distance from the lid margin and the lashes, which sets how much margin the method needs.
Skin type: in Fitzpatrick III to V skin, post-inflammatory pigment change after removal is the main cosmetic risk, so depth control and aftercare are planned for it.
Expectation: recurrence after every method is documented, and it is explained before anything is done rather than discovered afterwards.
Where the plaque is small and the lipids are the real finding, the consultation may end with a blood test and no procedure at all; see how consultations work.
Where it fits
Xanthelasma is the one cosmetic eyelid lesion that doubles as a lipid question, which is why Dr Sin Yong's order is cholesterol check first, removal planning second. It is told apart from milia and syringoma by its soft, flat, yellow look and its eyelid position. Plaques slowly enlarge over years and essentially never regress on their own; creams, acid kits and squeezing do not address them, and the method of removal is matched to the plaque's size and depth, with the chance of recurrence explained before anything is done. Full page: xanthelasma; the look-alikes on syringoma and milia.
Frequently Asked Questions
Ablative CO₂ or erbium laser is one of the established methods, with eye protection in place and the depth controlled to the thin skin of the lid. Whether laser, excision or a chemical agent is chosen depends on the size and depth of the plaque and how close it sits to the lid margin. Recurrence is possible after any method and is discussed first.
No. A milium is a hard, pearl-white keratin cyst that can be opened and expressed. Xanthelasma is a soft, flat, yellow plaque of lipid-laden cells in the dermis; there is nothing to express, and it raises a cholesterol question that a milium does not. The two are told apart by colour, texture and position at examination.
Not always, but about half of patients do have abnormal blood lipids, so a fasting lipid panel is standard advice. The plaque itself is benign; the test is about what it may be signalling.
It can. Recurrence after any modality is well documented, with substantial rates reported over years. The method is matched to size and depth, and the lipid picture is addressed alongside.
